Ontology highlight
ABSTRACT:
SUBMITTER: Hochhaus A
PROVIDER: S-EPMC8791110 | biostudies-literature | 2021 Dec
REPOSITORIES: biostudies-literature
Hematology. American Society of Hematology. Education Program 20211201 1
Treatment-free remission (TFR) is a new and significant goal of chronic myeloid leukemia management. TFR should be considered for patients in stable deep molecular response (DMR) after careful discussion in the shared decision-making process. Second-generation tyrosine kinase inhibitors (TKIs) improve the speed of response and the incidence of DMR. Treatment may be changed to a more active TKI to improve the depth of response in selected patients who have not reached DMR. Stem cell persistence i ...[more]